Effects of lowering LDL cholesterol on progression of kidney disease

Journal of the American Society of Nephrology

Volumn 25, Issue 8, 2014, Pages 1825-1833

  Haynes, Richard ^a   Lewis, David ^a   Emberson, Jonathan ^a   Reith, Christina ^a   Agodoa, Lawrence ^b   Cass, Alan ^c   Craig, Jonathan C ^d   De Zeeuw, Dick ^e   Feldt Rasmussen, Bo ^f   Fellstr'm, Bengt ^g   Levin, Adeera ^h   Wheeler, David C ⁱ   Walker, Rob ^j   Herrington, William G ^a   Baigent, Colin ^a   Landray, Martin J ^a  

^a CLINICAL TRIAL SERVICE UNIT   (United Kingdom)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^c MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

^d UNIVERSITY OF SYDNEY   (Australia)

^e UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^f Rigshospitalet   (Denmark)

^g UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^h UNIVERSITY OF BRITISH COLUMBIA   (Canada)

ⁱ UNIVERSITY COLLEGE LONDON   (United Kingdom)

^j UNIVERSITY OF OTAGO   (New Zealand)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; EZETIMIBE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; SIMVASTATIN; AZETIDINE DERIVATIVE; HYPOCHOLESTEROLEMIC AGENT;

ACUTE KIDNEY FAILURE; ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY FAILURE; COMPARATIVE STUDY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETIC NEPHROPATHY; DIALYSIS; DISEASE COURSE; END STAGE RENAL DISEASE; FEMALE; FOLLOW UP; HUMAN; KIDNEY DISEASE; KIDNEY POLYCYSTIC DISEASE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEINURIA; RANDOMIZED CONTROLLED TRIAL; RENOVASCULAR DISEASE; AGED; BLOOD; COMBINATION DRUG THERAPY; HEMODIALYSIS; INCIDENCE; KIDNEY FAILURE, CHRONIC; MIDDLE AGED; PATHOLOGY; TREATMENT OUTCOME;

AGED; ANTICHOLESTEREMIC AGENTS; AZETIDINES; CHOLESTEROL, LDL; DISEASE PROGRESSION; DRUG THERAPY, COMBINATION; EZETIMIBE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; RENAL DIALYSIS; SIMVASTATIN; TREATMENT OUTCOME;

EID: 84906791388     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2013090965     Document Type: Article

References (17)

1. Levey AS, Coresh J: Chronic kidney disease. Lancet 379: 165-180, 2012
2. Foley RN, Parfrey PS, Sarnak MJ: Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 32[Suppl 3]: S112-S119, 1998
3. Evans RW, Manninen DL, Garrison LP Jr., Hart LG, Blagg CR, Gutman RA, Hull AR, Lowrie EG: The quality of life of patients with end-stage renal disease. N Engl J Med 312: 553-559, 1985
4. US Renal Data System: 2010 Annual Data Report: Atlas of Chronic Kidney Disease. Costs of End-Stage Renal Disease, 2010. Available at: http://www.usrds.org/2010/pdf/v2-11.pdf. Accessed June 18, 2013
5. Jafar TH, Schmid CH, LandaM,Giatras I, Toto R, RemuzziG,MaschioG, Brenner BM, Kamper A, Zucchelli P, Becker G, Himmelmann A, Bannister K, Landais P, Shahinfar S, de Jong PE, de Zeeuw D, Lau J, Levey AS: Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. Ameta-analysis of patient-level data. Ann Intern Med 135: 73-87, 2001
6. Lewis EJ, Hunsicker LG, Clarke WR, Berl T, Pohl MA, Lewis JB, Ritz E, Atkins RC, Rohde R, Raz I; Collaborative Study Group: Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes.NEngl J Med 345: 851-860, 2001
7. Moorhead JF, Chan MK, El-Nahas M, Varghese Z: Lipid nephrotoxicity in chronic progressive glomerular and tubulo-interstitial disease. Lancet 2: 1309-1311, 1982
8. Tonelli M, Isles C, Craven T, Tonkin A, Pfeffer MA, Shepherd J, Sacks FM, Furberg C, Cobbe SM, Simes J, West M, Packard C, Curhan GC: Effect of pravastatin on rate of kidney function loss in people with or at risk for coronary disease. Circulation 112: 171-178, 2005
9. Sandhu S, Wiebe N, Fried LF, Tonelli M: Statins for improving renal outcomes: A meta-analysis. J Am Soc Nephrol 17: 2006-2016, 2006
10. Baigent C, Landray MJ, Reith C, Emberson J, Wheeler DC, Tomson C, Wanner C, Krane V, Cass A, Craig J, Neal B, Jiang L, Hooi LS, Levin A, Agodoa L,GazianoM, Kasiske B, Walker R,Massy ZA, Feldt-Rasmussen B, Krairittichai U, Ophascharoensuk V, Fellström B, Holdaas H, Tesar V, Wiecek A, Grobbee D, de Zeeuw D, Grönhagen-Riska C, Dasgupta T, Lewis D, HerringtonW,MafhamM,MajoniW,Wallendszus K, GrimmR, Pedersen T, Tobert J, Armitage J, Baxter A, Bray C, Chen Y, Chen Z, Hill M, Knott C, Parish S, Simpson D, Sleight P, Young A, Collins R; SHARP Investigators: The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): A randomised placebo-controlled trial. Lancet 377: 2181-2192, 2011
11. Sharp Collaborative Group: Study of Heart and Renal Protection (SHARP): Randomized trial to assess the effects of lowering low-density lipoprotein cholesterol among 9,438 patients with chronic kidney disease. Am Heart J 160: 785-794, e10, 2010
12. Baigent C, Blackwell L, Emberson J, Holland LE, Reith C, Bhala N, Peto R, Barnes EH, Keech A, Simes J, Collins R; Cholesterol Treatment Trialists' (CTT) Collaboration: Efficacy and safety of more intensive lowering of LDL cholesterol: A meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet 376: 1670-1681, 2010
13. Jha V, Garcia-GarciaG, Iseki K, Li Z, Naicker S, Plattner B, Saran R,Wang AY, Yang CW: Chronic kidney disease: Global dimension and perspectives. Lancet 382: 260-272, 2013
14. Stevens LA, Coresh J,Greene T, Levey AS: Assessing kidney function-measured and estimated glomerular filtration rate. N Engl J Med 354: 2473-2483, 2006
15. Li L, Astor BC, Lewis J, Hu B, Appel LJ, LipkowitzMS, Toto RD,Wang X, Wright JT Jr., Greene TH: Longitudinal progression trajectory of GFR among patients with CKD. Am J Kidney Dis 59: 504-512, 2012
16. Levey AS, Greene T, Kusek JW, Beck GJ; MDRD Study Group: A simplified equation to predict glomerular filtration rate from serum creatinine [Abstract]. J Am Soc Nephrol 11: 155A, 2000
17. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J; CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration): A new equation to estimate glomerular filtration rate. Ann Intern Med 150: 604-612, 2009